Zenapax
Active substance: daclizumab
daclizumab
Centralised EU authorisationWithdrawn
Marketing holder: Roche Registration Ltd.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 1 |
|
Registration
- Registration number
- EMEA/H/C/000198
- Registration status
- Withdrawn
- ATC code
- L04AA08
Sources
- product · EMA · EMEA/H/C/000198 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000198 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000198 · Verified 2026-10-09